Imbalance of the protease-antiprotease system against the background of chronic obstructive pulmonary disease in combination with ischemic heart disease

Imbalance of the protease-antiprotease system against the background of chronic obstructive pulmonary disease in combination with ischemic heart disease

Saved in:

Bibliographic Details
Main Author:	O. O. Kraidashenko
Format:	Article
Language:	English
Published:	Zaporizhzhia State Medical and Pharmaceutical University 2023-08-01
Series:	Patologìâ
Subjects:	ischemic heart disease chronic obstructive pulmonary disease matrix metalloproteinase 9 tissue inhibitor of metalloproteinases fibrosis
Online Access:	http://pat.zsmu.edu.ua/article/view/278133/281370
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Assessment of Matrix Metalloproteinases a Prognostic Indicator in Advanced Fibrotic Lung Disease: A Systematic Review
by: Mehvish Aqil, et al.
Published: (2025-04-01)

Gelatinases A and B activities in the serum of patients with various coronary artery disease stages
by: Radenković Sandra, et al.
Published: (2010-01-01)

DYNAMICS OF FIBROSIS MARKERS ON THE BACKGROUND OF TB/HIV CO-INFECTION TREATMENT
by: Olga SHEVCHENKO, et al.
Published: (2025-04-01)

Influence of diuretics with antialdosterone effect on the condition of extracellular matrix and early postinfarction remodeling of the left ventricle in patients with Q-wave myocardial infarction
by: S. M. Kyselov
Published: (2015-08-01)

Expression of MMP-2, MMP-9 and TIMP-2 in pituitary tumors and their relationship with cavernous sinus invasion
by: Ane Caroline Thé B Freire, et al.
Published: (2025-01-01)

Local proteolytic system indicators as suspective factors of keratolysis development after urgent keratoplasty
by: E. V. Chentsova, et al.
Published: (2024-07-01)

Gender peculiarities and prognostic value of matrix metalloproteinase and their inhibitors system in patients with acute Q-wave left ventricle myocardial infarction
by: S. M. Kyselov
Published: (2015-02-01)

Changes in the extracellular matrix under the influence of anticoagulant therapy in patients with Q-myocardial infarction after thrombolysis
by: S. M. Kyselov
Published: (2014-12-01)

The content of matrix metalloproteinase-1, -9 and tissue inhibitor of matrix metalloproteinase-1 in patients with bronchial asthma and obesity
by: V. V. Kachkovska, et al.
Published: (2023-12-01)

Dynamic changes of serum matrix metalloproteinases and tissue inhibitors in Kawasaki disease: implications for coronary artery lesions persistence
by: Yaqi Li, et al.
Published: (2025-06-01)

Correlation between markers of fibrosis and myocardial remodeling in patients with various course of hypertrophic cardiomyopathy
by: F. M. Bogatyreva, et al.
Published: (2022-03-01)

Matrix metalloproteinases and their tissue inhibitors as upcoming biomarker signatures of connective tissue diseases-related interstitial lung disease: towards an earlier and accurate diagnosis
by: Verónica Pulito-Cueto, et al.
Published: (2025-02-01)

Activity of matrix metalloproteinases and their tissue inhibitors in serum in chronic granulating periodontitis
by: D. I. Haidash, et al.
Published: (2019-12-01)

Study of matrix metalloproteinases and their tissue inhibitor in patients with ovarian tumors
by: K. P. Lactionov, et al.
Published: (2014-07-01)

Gaylussacin, a stilbene glycoside, inhibits chronic obstructive pulmonary disease in mice
by: Hye-Young Min, et al.
Published: (2025-09-01)

Comparative analysis of content of the matrix metalloproteinase-9 in patients with acute cerebral strokes of different types
by: E. V. Baranova
Published: (2014-10-01)

Comparative characteristic of methods for determining the inflammation marker matrix metalloproteinase-9
by: E. V. Baranova, et al.
Published: (2014-12-01)

ISCHEMIC INJURY OF KIDNEY ALLOGRAFTS AND EXPRESSION OF MATRIX METALLOPROTEINASES
by: M. L. Arefjev, et al.
Published: (2011-06-01)

Aspergillusidone G Exerts Anti-Neuroinflammatory Effects via Inhibiting MMP9 Through Integrated Bioinformatics and Experimental Analysis: Implications for Parkinson’s Disease Intervention
by: Fangfang Ban, et al.
Published: (2025-04-01)

Matrix Metalloproteinases in Ureteropelvic Junction Obstruction: Their Role in Pathogenesis and Their Use as Clinical Markers
by: Giusi Alberti, et al.
Published: (2025-03-01)

Relationships between MMP-2, MMP-9, and ADAMDEC1 serum and tissue levels in patients with colorectal cancer
by: Zahra Mozooni, et al.
Published: (2025-04-01)

Parameters of the mmp / timp system in assessing the clinical course of pulmonary tuberculoma
by: D. S. Esmedlyaeva, et al.
Published: (2024-04-01)

A Noninvasive Predictors of Significant Histological Activity in Chronic Liver Diseases: The Role of Matrix Metalloproteinases
by: A. V. Yagoda, et al.
Published: (2025-05-01)

The concentration of matrix metalloproteinase 9 in the tumor and peritumoral tissue as prognostic marker in breast cancer patients
by: Cvetković Danijela M., et al.
Published: (2019-01-01)

Plasma Markers of Degradation of Extracellular Matrix with Intrauterine Herpes Infection
by: S. N. Beniova, et al.
Published: (2016-11-01)

Content of matrix metalloproteinases in the blood of hypertensive patients with a high cardiovascular risk receiving statin therapy
by: V. P. Mikhin, et al.
Published: (2022-11-01)

Investigation of the Neuroprotective Effect of Riluzole on Matrix Metalloproteinases in an Experimental Model of Glaucoma
by: Fatma Yildiz, et al.
Published: (2024-04-01)

Matrix metalloproteinase-9, its inhibitor-1 and interleukines in experimental traumatic brain injury
by: S. V. Ziablitsev, et al.
Published: (2016-12-01)

Role of Gene Polymorphisms of Matrix Metalloproteinases-2, -3 and -13 in the Development of Coronary Artery Atherosclerosis in Patients with Primary Polyosteoarthrosis
by: O. O. Portyannikova, et al.
Published: (2020-03-01)

Matrix metalloproteinase system in blood serum in patients with squamous cell head and neck carcinomas
by: Ye. V. Klisho, et al.
Published: (2011-02-01)

Age-associated level of myocardial fibrosis markers and chemokines in patients with acute coronary syndrome
by: O. A. Osipova, et al.
Published: (2021-09-01)

Role of MMP-2, MMP-9, TIMP-1, and TIMP-2 in children with ventricular septal defect
by: Nina Maric, et al.
Published: (2024-10-01)

Genetic polymorphisms of matrix metalloproteinase-9, tissue inhibitor of matrix metalloproteinase-1 and development of postoperative atrial fibrillation in elderly patients
by: A. O. Rubanenko, et al.
Published: (2018-11-01)

Monocyte/HDL Cholesterol Ratio and Matrix Metalloproteinase-2 in Obstructive Sleep Apnea Syndrome Without Heart Disease
by: Gökçe Külah, et al.
Published: (2025-06-01)

Matrix metalloproteinases and their inhibitors
by: O. S. Grigorkevich, et al.
Published: (2019-02-01)

Factors associated with deterioration of myocardial inotropic function in patients with coronary artery disease
by: O. A. Osipova, et al.
Published: (2024-09-01)

ПРОГНОЗИРОВАНИЕ ТРАНСФОРМАЦИИ РЕЦИДИВИРУЮЩЕЙ ФОРМЫ ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ В ХРОНИЧЕСКУЮ У ПАЦИЕНТОВ С АРТЕРИАЛЬНОЙ ГИПЕРТОНИЕЙ
by: Н. Е. Григориади, et al.
Published: (2014-04-01)

Features of the level of matrix metalloproteinase-2, -3, -9 and tissue inhibitors of metalloproteinases-1, -2, -3, -4 in the aqueous humor of patients with primary open-angle glaucoma
by: V. V. Chernykh, et al.
Published: (2022-01-01)

Applications of Matrix Metalloproteinase-9-Related Nanomedicines in Tumors and Vascular Diseases
by: Xuying Li, et al.
Published: (2025-04-01)

The predictive function of rates of matrix metalloproteinases/inhibitors system when assessing reparative changes in the lung tissue in those with infiltrate pulmonary tuberculosis
by: D. S. Esmedlyaevа, et al.
Published: (2018-10-01)